| |
Article Title |
Author(s) |
Type (Status) |
Available Online |
|
Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia
DOI: 10.1016/j.ijantimicag.2011.11.016
Abstract: JNJ-Q2 is a broad-spectrum fluoroquinolone with bactericidal activity against Gram-positive and Gram-negative pathogens and is currently in clinical development for the treatment of communit...
|
Douglas J. Biedenbach,
David J. Farrell,
Robert K. Flamm,
Lisa C. Liverman,
Gail McIntyre,
Ronald N. Jones
et al.
|
Full-length article
(In Press Corrected Proof)
|
06 February 2012 |
|
Commentary on: Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
DOI: 10.1016/j.ijantimicag.2011.11.015
The review in this journal by Shen et al. addresses one of the current controversies regarding antimicrobial therapy: which drug should be selected for the initial treatment of community-acquired pne...
|
Gabriel Levy Hara
|
Discussion
(In Press Corrected Proof)
|
03 February 2012 |
|
Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
DOI: 10.1016/j.ijantimicag.2011.11.014
Abstract: The role of fluoroquinolones (FQs) as empirical therapy for community-acquired pneumonia (CAP) remains controversial in countries with high tuberculosis (TB) endemicity owing to the possibil...
|
Gwan-Han Shen,
Thomas Chang-Yao Tsao,
Shang-Jyh Kao,
Jen-Jyh Lee,
Yen-Hsu Chen,
Wei-Chung Hsieh,
Gwo-Jong Hsu,
Yen-Tao Hsu,
Ching-Tai Huang,
Yeu-Jun Lau,
Shih-Ming Tsao,
Po-Ren Hsueh
et al.
|
Short survey
(In Press Corrected Proof)
|
27 January 2012 |
|
Cytosine deoxyribonucleoside anti-HIV analogues: a small chemical substitution allows relevant activities
DOI: 10.1016/j.ijantimicag.2011.11.013
Abstract: The search for new nucleoside analogue compounds targeting the virally encoded reverse transcriptase was developed by modifying the nucleoside structure to create inhibitor compounds. In thi...
|
Francesco Scaglione,
Liberato Berrino
|
Short survey
(In Press Corrected Proof)
|
24 January 2012 |
|
Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium
DOI: 10.1016/j.ijantimicag.2011.11.011
Abstract: We assessed the in vitro susceptibility of Streptococcus pneumoniae isolates from patients with confirmed community-acquired pneumonia (CAP) to β-lactams, macrolides and fluoroquinolones and...
|
Ann Lismond,
Sylviane Carbonnelle,
Jan Verhaegen,
Patricia Schatt,
Annelies De Bel,
Paul Jordens,
Frédérique Jacobs,
Anne Dediste,
Frank Verschuren,
Te-Din Huang,
Paul M. Tulkens,
Youri Glupczynski,
Françoise Van Bambeke
et al.
|
Full-length article
(In Press Corrected Proof)
|
16 January 2012 |
|
Efficacy and mechanism of action of arachidonic acid in the treatment of hamsters infected with Schistosoma mansoni or Schistosoma haematobium
DOI: 10.1016/j.ijantimicag.2011.08.019
Abstract: We have recently shown that in vitro and in vivo exposure of Schistosoma mansoni and Schistosoma haematobium to 5–10mM arachidonic acid (ARA) induces parasite surface membrane disintegration...
|
Rashika El Ridi,
Hatem Tallima,
Mohamed Salah,
Marwa Aboueldahab,
Omar M. Fahmy,
Mohammad Farhan Al-Halbosiy,
Soheir S. Mahmoud
et al.
|
Full-length article
(In Press Corrected Proof)
|
13 January 2012 |
|
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin
DOI: 10.1016/j.ijantimicag.2011.11.012
Alternative treatment strategies are needed to optimise the efficacy of treatment for infections due to multidrug-resistant pathogens . Pharmacokinetic and pharmacodynamic data for carbapenems, in con...
|
Anucha Apisarnthanarak,
Linda M. Mundy
|
Correspondence
(In Press Corrected Proof)
|
11 January 2012 |
|
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation
DOI: 10.1016/j.ijantimicag.2011.11.005
Abstract: Community-acquired pneumonia (CAP) is a serious infection requiring hospitalisation in 20% of cases. The novel cephalosporin ceftobiprole has microbiological activity against the major bacte...
|
Susan C. Nicholson,
Tobias Welte,
Thomas M. File,
Richard S. Strauss,
Bart Michiels,
Pratibha Kaul,
Dainius Balis,
Deborah Arbit,
Karen Amsler,
Gary J. Noel
et al.
|
Full-length article
(In Press Corrected Proof)
|
10 January 2012 |
|
Intracellular concentrations of micafungin in different cellular compartments of the peripheral blood
DOI: 10.1016/j.ijantimicag.2011.11.006
Abstract: Whilst micafungin serum concentrations are well studied, little is known about its concentrations within cellular compartments of the peripheral blood. Hence, in this study blood samples wer...
|
Fedja Farowski,
Oliver A. Cornely,
Jörg J. Vehreschild,
Tim Bauer,
Pia Hartmann,
Angela Steinbach,
Maria J.G.T. Vehreschild,
Christof Scheid,
Carsten Müller
et al.
|
Full-length article
(In Press Corrected Proof)
|
10 January 2012 |
|
Mechanism of resistance of a highly carbapenem-resistant Klebsiella oxytoca isolate and comparison of susceptibility to five carbapenems
DOI: 10.1016/j.ijantimicag.2011.11.009
Klebsiella oxytoca is an important opportunistic pathogen that causes septicaemia, pneumonia and urinary tract infections in hospitalised patients, including neonates. Whilst most Klebsiella spp., inc...
|
Takehiko Sho,
Tetsuro Muratani,
Yukihiro Mizokami,
Ryoichi Hamasuna,
Naoki Fujimoto,
Tetsuro Matsumoto
et al.
|
Correspondence
(In Press Corrected Proof)
|
09 January 2012 |
|
Purified 1′acetoxychavicol acetate (1′ACA) from galangal spice affects membrane fatty acid composition and triggers a cell envelope stress response in Staphylococcus aureus
DOI: 10.1016/j.ijantimicag.2011.11.010
Staphylococcus aureus is a significant cause of community- and hospital-acquired infections worldwide. New effective control measures for S. aureus are needed and natural antimicrobial compounds from ...
|
Nimsha S. Weerakkody,
William M. Smith,
Deirdre Mikkelsen,
Jennifer Waanders,
Graham Kerven,
Nola Caffin,
Gary A. Dykes,
Mark S. Turner
et al.
|
Correspondence
(In Press Corrected Proof)
|
09 January 2012 |
|
Molecular characterisation of high-level gentamicin-resistant enterococci from bloodstream infections in Denmark: first description of clonal spread of aph(2′′)-Ib
DOI: 10.1016/j.ijantimicag.2011.11.007
Enterococcal bloodstream infections (BSIs) are emerging in Danish hospitals . In the present study, high-level gentamicin-resistant (HLGR) Enterococcus faecalis and HLGR Enterococcus faecium isolates ...
|
Anette M. Hammerum,
Camilla H. Lester,
Stefan S. Olsen,
Anette Holm,
Dennis S. Hansen,
Henrik C. Schønheyder
et al.
|
Correspondence
(In Press Corrected Proof)
|
09 January 2012 |
|
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany
DOI: 10.1016/j.ijantimicag.2011.10.015
Abstract: The aim of this study was to determine the current susceptibility of hospital isolates of contemporary Gram-negative pathogens to the carbapenems doripenem, imipenem and meropenem. Between M...
|
Giuseppe Valenza,
Harald Seifert,
Sabine Decker-Burgard,
Joerg Laeuffer,
Ian Morrissey,
Reinier Mutters,
for the COMPACT Germany Study Group
et al.
|
Short communication
(In Press Corrected Proof)
|
09 January 2012 |
|
Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase
DOI: 10.1016/j.ijantimicag.2011.11.003
Abstract: Fifteen carbapenem-non-susceptible Escherichia coli isolates obtained during the period May 2010 to April 2011 in a hospital and a long-term care facility (LTCF) in Larissa (Central Greece) ...
|
Angeliki Mavroidi,
Vivi Miriagou,
Ergina Malli,
Angelos Stefos,
George N. Dalekos,
Leonidas S. Tzouvelekis,
Efthymia Petinaki
et al.
|
Short communication
(In Press Corrected Proof)
|
09 January 2012 |
|
Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA)
DOI: 10.1016/j.ijantimicag.2011.09.029
Abstract: The rapid dissemination of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA) since the early 2000s and the appearance of new successful lineages is a matter of concern....
|
Robert Skov,
Keryn Christiansen,
Stephanie J. Dancer,
Robert S. Daum,
Matthew Dryden,
Yhu-Chering Huang,
Franklin D. Lowy
et al.
|
Short survey
(In Press Corrected Proof)
|
09 January 2012 |
|
Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods
DOI: 10.1016/j.ijantimicag.2011.09.030
Abstract: This article reviews recent findings on the global epidemiology of healthcare-acquired/associated (HA), community-acquired/associated (CA) and livestock-associated (LA) meticillin-resistant ...
|
Stefania Stefani,
Doo Ryeon Chung,
Jodi A. Lindsay,
Alex W. Friedrich,
Angela M. Kearns,
Henrik Westh,
Fiona M. MacKenzie
et al.
|
Short survey
(In Press Corrected Proof)
|
09 January 2012 |
|
How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics
DOI: 10.1016/j.ijantimicag.2011.11.002
Abstract: Optimising antimicrobial dosing for critically ill patients is highly challenging and when it is not achieved can lead to worse patient outcomes. To this end, use of dosing regimens recommen...
|
Jason A. Roberts,
Gavin M. Joynt,
Gordon Y.S. Choi,
Charles D. Gomersall,
Jeffrey Lipman
et al.
|
Short survey
(In Press Corrected Proof)
|
09 January 2012 |
|
Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis
DOI: 10.1016/j.ijantimicag.2011.10.014
Abstract: Meningitis is one of the most fatal manifestations of cryptococcosis, even with specific treatment. Combination of a prompt diagnosis and appropriate therapy are critical to reduce the funga...
|
Alexandra F. Gazzoni,
Javier Capilla,
Emilio Mayayo,
Josep Guarro
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice
DOI: 10.1016/j.ijantimicag.2011.11.008
Abstract: Leishmaniasis is one of the most serious worldwide diseases caused by protozoan parasites of the Leishmania genus, affecting millions of people around the world. All currently available trea...
|
Joseane Lima Prado Godinho,
Cíntia Simas-Rodrigues,
Rosane Silva,
Turán Peter Ürmenyi,
Wanderley de Souza,
Juliany Cola Fernandes Rodrigues
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli
DOI: 10.1016/j.ijantimicag.2011.10.012
Abstract: New Delhi metallo-β-lactamase-1 (NDM-1)-producing Enterobacteriaceae have emerged as a global threat. The aim of this study was to assess the efficacies of colistin and tigecycline in an exp...
|
Fernando Docobo-Pérez,
Patrice Nordmann,
Juan Domínguez-Herrera,
Rafael López-Rojas,
Younes Smani,
Laurent Poirel,
Jerónimo Pachón
et al.
|
Short communication
(In Press Corrected Proof)
|
09 December 2011 |
|
Prevalence of New Delhi metallo-β-lactamase (NDM-1)-positive bacteria in a tertiary care centre in Pune, India
DOI: 10.1016/j.ijantimicag.2011.09.027
Metallo-β-lactamases (MBLs) are molecularly diverse carbapenemases that are emerging as a global health threat to mankind. The latest addition to the armamentarium of MBLs is the New Delhi MBL (NDM-1)...
|
Renu Bharadwaj,
Suvarna Joshi,
Vaishali Dohe,
Vaishali Gaikwad,
Girish Kulkarni,
Yogesh Shouche
et al.
|
Correspondence
(In Press Corrected Proof)
|
05 December 2011 |
|
Optimising amikacin regimens in septic patients
DOI: 10.1016/j.ijantimicag.2011.10.007
I read with interest the article by Gálvez et al. dealing with amikacin regimens to administer in septic patients. The authors confirmed our data from a previously published study in which higher th...
|
Fabio Silvio Taccone
|
Correspondence
(In Press Corrected Proof)
|
28 November 2011 |
|
Molecular characterisation of high-level ciprofloxacin-resistant Salmonella enterica with multiple antibiotic resistance and class 1 integrons isolated from imported foods
DOI: 10.1016/j.ijantimicag.2011.10.003
Dissemination of antibiotic resistance amongst pathogenic bacteria has been a concern for public health since commercialisation of antimicrobial drugs. This includes (i) spread of antibiotic resistanc...
|
Tatsuya Akiyama,
Ashraf A. Khan,
M.S. Nawaz,
Christine S. West
|
Correspondence
(In Press Corrected Proof)
|
21 November 2011 |
|
Effect of vinyl sulfone inhibitors of cysteine proteinases on Tritrichomonas foetus infection
DOI: 10.1016/j.ijantimicag.2011.09.026
Abstract: Tritrichomonas foetus is a sexually transmitted protozoon that causes genital inflammation and adverse pregnancy outcomes in cattle. Cysteine proteinases (CPs) released by T. foetus degrade ...
|
Eduardo R. Cobo,
Sharon L. Reed,
Lynette B. Corbeil
|
Short communication
(In Press Corrected Proof)
|
21 November 2011 |
|
Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA)
DOI: 10.1016/j.ijantimicag.2011.09.023
Abstract: Between 2003 and 2009, the prevalence of extensively drug-resistant Pseudomonas aeruginosa (XDR-PA) increased significantly in northern Taiwan from 1.0% to 2.1%. Molecular methods were used ...
|
Jwu-Ching Shu,
Ju-Hsin Chia,
Leung-Kei Siu,
An-Jing Kuo,
Shu-Huan Huang,
Lin-Hui Su,
Tsu-Lan Wu
et al.
|
Full-length article
(In Press Corrected Proof)
|
14 November 2011 |
|
WITHDRAWN: Synergistic interaction of aciclovir and a helicase-primase inhibitor, BAY 57-1293, against herpes simplex virus type 1
DOI: 10.1016/j.ijantimicag.2008.11.009
This article has been withdrawn at the request of the author(s). The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://ww...
|
Manish Kumar,
Hilary W. Thompson,
Emily D. Varnell,
Herbert E. Kaufman
|
Retraction
(In Press Corrected Proof)
|
27 January 2009 |
|
WITHDRAWN: High frequency of mutations in the rpoB gene in rifampicin-resistant clinical isolates of Mycobacterium tuberculosis from Iran
DOI: 10.1016/j.ijantimicag.2007.08.010
This article has been withdrawn consistent with Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). The Publisher apologizes for any inconvenience this may cause.
|
Farahnoosh Doustdar,
Azar Dokht Khosravi,
Parissa Farnia,
Ahmad Reza Bahremand
|
Retraction
(In Press Corrected Proof)
|
16 October 2007 |